Summarized findings of studies investigating the role of surveillance imaging in DLBCL and HL
| Reference (study) . | Disease . | Modality . | No. of patients . | No. of relapses (%) . | No. of relapses outside surveillance visit (% of relapses) . | Asymptomatic relapses (% of relapses) . |
|---|---|---|---|---|---|---|
| 7 (Mayo) | DLBCL | CT or PET | 552 | 112 (20) | 69 (62) | 13 (19) |
| 7 (Lyon) | DLBCL | CT | 222 | 55 (25) | 34 (62) | 6 (11) |
| 8 | DLBCL | CT | 117 | 35 (30) | 33 (94) | 2 (6) |
| 9 | DLBCL | PET/CT | 116 | 13 (12) | 7 (54) | 6 (46) |
| 10 | DLBCL | CT or PET | 625 | 50 (8) | 31 (62) | 19 (38) |
| 11 | DLBCL | CT | 341 | 113 (33) | 88 (78) | 25 (22) |
| 12 | DLBCL | PET | 119 | 31 (26) | 22 (71) | 9 (29) |
| 13 | DLBCL | CT or PET | 106 | 15 (14) | — | — |
| 14 | DLBCL | PET | 75 | 23 (31) | 20 (87) | 3 (13) |
| 15 | HL/DLBCL | PET, CT, or gallium | — | 125 (N/A) | 78 (62) | 47 (38) |
| 16 | HL/DLBCL | PET/CT | ||||
| 17 | HL | PET/CT | 161 | 22 (14) | 12 (55) | 10 (45) |
| 18 | HL | CT or PET | 305 | 28 (9) | 8 (29) | 17 (61) |
| 19 | HL | CT or PET | 174 | 6 (3) | — | — |
| 20 | HL | CT or PET | 36 | 5 (14) | — | — |
| 21 | HL | PET/CT | 150 | 40 (27) | 15 (38) | 25 (63) |
| Reference (study) . | Disease . | Modality . | No. of patients . | No. of relapses (%) . | No. of relapses outside surveillance visit (% of relapses) . | Asymptomatic relapses (% of relapses) . |
|---|---|---|---|---|---|---|
| 7 (Mayo) | DLBCL | CT or PET | 552 | 112 (20) | 69 (62) | 13 (19) |
| 7 (Lyon) | DLBCL | CT | 222 | 55 (25) | 34 (62) | 6 (11) |
| 8 | DLBCL | CT | 117 | 35 (30) | 33 (94) | 2 (6) |
| 9 | DLBCL | PET/CT | 116 | 13 (12) | 7 (54) | 6 (46) |
| 10 | DLBCL | CT or PET | 625 | 50 (8) | 31 (62) | 19 (38) |
| 11 | DLBCL | CT | 341 | 113 (33) | 88 (78) | 25 (22) |
| 12 | DLBCL | PET | 119 | 31 (26) | 22 (71) | 9 (29) |
| 13 | DLBCL | CT or PET | 106 | 15 (14) | — | — |
| 14 | DLBCL | PET | 75 | 23 (31) | 20 (87) | 3 (13) |
| 15 | HL/DLBCL | PET, CT, or gallium | — | 125 (N/A) | 78 (62) | 47 (38) |
| 16 | HL/DLBCL | PET/CT | ||||
| 17 | HL | PET/CT | 161 | 22 (14) | 12 (55) | 10 (45) |
| 18 | HL | CT or PET | 305 | 28 (9) | 8 (29) | 17 (61) |
| 19 | HL | CT or PET | 174 | 6 (3) | — | — |
| 20 | HL | CT or PET | 36 | 5 (14) | — | — |
| 21 | HL | PET/CT | 150 | 40 (27) | 15 (38) | 25 (63) |
—, unknown/not reported; N/A, not applicable.